Dr. Wang is Associate Professor of Biostatistics and Bioinformatics at Duke University. In the past ten years, he has been involved in the design and analysis of cancer clinical trials and translational studies in the Alliance. He serves as Associate Director of Biostatistics and the lead statistician for the Respiratory Committee of the Alliance. Dr. Wang’s methodological research is focused on the development of novel statistical methods for biomarker-integrated cancer clinical trials and for analyzing data from multiple sources subject to lack of generalizability and selection bias. He has been the Project Director/Principal Investigator for National Cancer Institute-funded projects on biomarker validation under test-dependent sampling and pooled analysis of clinical trials data assembled from multiple sources on elderly lung cancer patients.